Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Assessing usability of QIAreach QuantiFERON-TB platform in a high tuberculosis prevalence, low-resource setting

Conceptor Kaaba, Maria Ruperez, Barry Kosloff, Nduku Ndunda, Kwame Shanaube, Helen Ayles on behalf of the TREATS Study Team
ERJ Open Research 2021 7: 00511-2021; DOI: 10.1183/23120541.00511-2021
Conceptor Kaaba
1Zambart, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Conceptor Kaaba
  • For correspondence: conceptor@zambart.org.zm
Maria Ruperez
2London School of Hygiene and Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barry Kosloff
1Zambart, Lusaka, Zambia
2London School of Hygiene and Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nduku Ndunda
3Cepheid Middle East, a Danaher company FZ LLC, Dubai, United Arab Emirates
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kwame Shanaube
1Zambart, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen Ayles
1Zambart, Lusaka, Zambia
2London School of Hygiene and Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 7 no. 4
DOI 
https://doi.org/10.1183/23120541.00511-2021

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received August 17, 2021
  • Accepted October 27, 2021
  • Published online December 27, 2021.

Article Versions

  • previous version (November 25, 2021 - 06:04).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright ©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org

Author Information

  1. Conceptor Kaaba1⇑,
  2. Maria Ruperez2,
  3. Barry Kosloff1,2,
  4. Nduku Ndunda3,
  5. Kwame Shanaube1 and
  6. Helen Ayles1,2
  7. on behalf of the TREATS Study Team
  1. 1Zambart, Lusaka, Zambia
  2. 2London School of Hygiene and Tropical Medicine, London, UK
  3. 3Cepheid Middle East, a Danaher company FZ LLC, Dubai, United Arab Emirates
  1. Conceptor Kaaba (conceptor{at}zambart.org.zm)
View Full Text

Funding

  • QIAGEN (Hilden, Germany)

    Provided test kits free of charge
  • European and Developing Countries Clinical Trials Partnership

    Grant number RIA2016S-1632-TREATS

Article usage

Article usage: November 2021 to December 2022

AbstractFullPdf
Nov 2021204412
Dec 2021458624
Jan 2022610652
Feb 202245946
Mar 202296036
Apr 202204723
May 202255833
Jun 202204121
Jul 202233214
Aug 202224917
Sep 202244919
Oct 202266825
Nov 20221177
Dec 20221188

Altmetrics

PreviousNext
Back to top
Vol 7 Issue 4 Table of Contents
ERJ Open Research: 7 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Assessing usability of QIAreach QuantiFERON-TB platform in a high tuberculosis prevalence, low-resource setting
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Assessing usability of QIAreach QuantiFERON-TB platform in a high tuberculosis prevalence, low-resource setting
Conceptor Kaaba, Maria Ruperez, Barry Kosloff, Nduku Ndunda, Kwame Shanaube, Helen Ayles
ERJ Open Research Oct 2021, 7 (4) 00511-2021; DOI: 10.1183/23120541.00511-2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Assessing usability of QIAreach QuantiFERON-TB platform in a high tuberculosis prevalence, low-resource setting
Conceptor Kaaba, Maria Ruperez, Barry Kosloff, Nduku Ndunda, Kwame Shanaube, Helen Ayles
ERJ Open Research Oct 2021, 7 (4) 00511-2021; DOI: 10.1183/23120541.00511-2021
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Acknowledgement
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Exertional oscillatory ventilation in chronic dyspnoea
  • COVID-19 in patients with pulmonary alveolar proteinosis
  • Fatigue and signs of sleep apnoea after COVID-19
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society